Completed PHASE3 INTERVENTIONAL 2-arm NCT01328912

Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients

Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients: A Randomized Controlled Trial

Sponsor: Queen's University

Conditions Death Low Cardiac Output Syndrome Myocardial Infarction Pulmonary Failure Renal Failure Stroke

Interventions Remote ischemic preconditioning stimulus control

Updated 7 times since 2017 Last updated: Feb 4, 2016 Started: Feb 29, 2012 Primary completion: Feb 29, 2016 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01328912, this PHASE3 trial focuses on Death and Low Cardiac Output Syndrome and remains completed. Sponsored by Queen's University, it has been updated 7 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Jun 2025 — Present [monthly]

Completed PHASE3
Apr 2025 — Jun 2025 [monthly]

Completed PHASE3
Sep 2024 — Apr 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Queen's University

Data source: Queen's University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kingston, Canada